Legal Representation
Attorney
Cynthia R. Adwere
USPTO Deadlines
Application History
10 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 27, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Dec 27, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Apr 26, 2005 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Feb 1, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jan 12, 2005 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Dec 1, 2004 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Nov 26, 2004 | ALIE | A | ASSIGNED TO LIE | Loading... |
Nov 23, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 22, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 5, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, antibodies used to prevent, treat and diagnose diseases, namely, auto-immune conditions, inflammatory conditions, allergic conditions, and cancer
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical drug development services; development of antibodies to treat autoimmune and inflammatory diseases and conditions, asthma, and cancer
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042